Michael A. Jenike - McLean Hospital - Harvard University

30
172. Keuthen N, Ricciardi JN, Baer L, Jenike MA, Buttolph ML. Psychiatric
comorbidity in chronic hairpulling and trichotillomania. (submitted).
173. The Fluoxetine Collaborative Research Team. A fixed-dose multi-center
investigation of fluoxetine in the treatment of obsessive-compulsive disorder.
(submitted).
174. O'Sullivan RL, Borgmann AS, Jenike MA. Late onset trichotillomania.
(submitted).
175. Greist JH, Jenike MA, Lieberman JA, Rasmussen SA. Efficacy of fluvoxamine in
obsessive-compulsive disorder: Results of a multicenter, double-blind, placebocontrolled
trial. (submitted).
176. O'Sullivan RL, Keuthen NJ, Ricciardi J, Jenike MA. Sertraline treatment of
trichotillomania: An open trial. (submitted).
177. Grachev ID, Rauch SL, O’Sullivan RL, Breiter HC, Baer L, Kennedy DN, Shera
DM, Savage CR, Keuthen NJ, Caviness VS, Jenike MA. MRI-based topographic
parcellation of human neocortex in trichotillomania: A hypothesis generating
post-hoc analysis. (submitted).
178. The Paroxetine Obsessive-Compulsive Disorders Study Group. Efficacy of fixeddoses
of paroxetine in the treatment of obsessive-compulsive disorder. A
randomized, double-blind, placebo-controlled trial. (submitted).
179. Brown HD, Kosslyn SM, Wilhelm S, Moretti C, Reid N, Savage C, Jenike MA.
Can patients with obsessive-compulsive disorder discriminate between percepts
and mental images? Replication and further investigations. (submitted).
180. The Paroxetine Obsessive-Compulsive Disorders Study Group. Long-term
treatment and prevention of relapse of obsessive-compulsive disorder with
paroxetine. (submitted).
181. Bush G, Whalen PJ, Rosen BR, Jenike MA, Rauch SL. The digital Stroop test: A
novel interference task specialized for functional neuroimaging - validation study
with functional MRI. (in preparation).
182. Whalen PJ, Bush G, McNally R, Wilhelm S, Jenike MA, Rauch SL. Functional
MRI study of the digital emotional stroop task. (in preparation).
183. Mataix-Cols D, Baer L, Rauch SL, Manzo P, Jenike MA. Symptom subtypes
predicting outcome with selective 5-HT reuptake inhibitors and placebo in the
treatment of obsessive-compulsive disorder. (submitted).
184. Price BH, Baral I, Cosgrove R, Rauch S, Nierenberg A, Jenike M, Cassem E: